Comorbidade entre transtorno bipolar e transtorno obsessivo-compulsivo: aspectos epidemiológicos, clínicos e terapêuticos.

Autores

DOI:

https://doi.org/10.25118/2763-9037.2022.v12.295

Palavras-chave:

Transtorno Bipolar, Transtorno Obsessivo-Compulsivo, Comorbidade

Resumo

Introdução: O transtorno bipolar (TB) e o transtorno obsessivo-compulsivo (TOC) são altamente comórbidos. Esta comorbidade está associada a impacto clínico significativo. Este artigo revisa os dados disponíveis sobre aspectos epidemiológicos, características clínicas e opções de tratamento da comorbidade TB-TOC. Métodos: Foi realizada revisão bibliográfica não sistemática na base de dados PUBMED, no idioma inglês. As seguintes palavras-chave foram incluídas na busca: obsessive-compulsive disorder, bipolar disorder, comorbidity. Resultados: Entre as amostras de pacientes com TB, a prevalência de TOC comórbido foi estimada em cerca de 17%. Entre as amostras de pacientes com TOC, a prevalência de TB foi estimada em, aproximadamente, 18%. Os dados sobre a validade diagnóstica da comorbidade são limitados. Os pacientes com TB-TOC parecem apresentar curso episódico dos sintomas obsessivo-compulsivos (SOC) com maior frequência do que os pacientes com TOC sem TB. A comorbidade parece estar associada à maior número total de episódios depressivos e à ocorrência mais frequente de comportamentos suicidas. Conteúdos obsessivos de simetria, agressão, religiosidade e acumulação parecem ser mais frequentes em pacientes com TB-TOC. O uso de estabilizadores do humor é a principal estratégia de tratamento. Conclusão: A prevalência da comorbidade parece ser relevante. O TB-TOC pode estar associado à caracteristicas clínicas particulares. Os dados sobre a validade diagnóstica da comorbidade são inconclusivos. A estabilização do humor é o primeiro objetivo no manejo clínico.

Downloads

Não há dados estatísticos.

Métricas

Carregando Métricas ...

Referências

Amerio A, Stubbs B, Odone A, Tonna M, Marchesi C, Ghaemi SN. The prevalence and predictors of comorbid bipolar disorder and obsessive-compulsive disorder: a systematic review and meta-analysis. J Affect Disord. 2015;186:99–109. http://dx.doi.org/10.1016/j.jad.2015.06.005 PMid:26233320

Jeon S, Baek JH, Yang SY, Choi Y, Ahn SW, Ha K, Hong KS. Exploration of comorbid obsessive-compulsive disorder in patients with bipolar disorder: the clinic-based prevalence rate, symptoms nature and clinical correlates. J Affect Disord. 2018;225:227–33. https://doi.org/10.1016/j.jad.2017.08.012 - PMid:28841485

Domingues-Castro MS, Torresan RC, Shavitt RG, Fontenelle LF, Ferrão YA, Rosário MC, Torres AR. Bipolar disorder comorbidity in patients with obsessive-compulsive disorder: prevalence and predictors. J Affect Disord. 2019;256(June):324–30. https://doi.org/10.1016/j.jad.2019.06.018 PMid:31201983

Timpano KR, Rubenstein LM, Murphy DL. Phenomenological features and clinical impact of affective disorders in OCD: a focus on the bipolar disorder and ocd connection. Depress Anxiety. 2012;29(3):226–33. https://doi.org/10.1002/da.20908 - PMid:22109969 - PMCid:PMC3322278

Del Casale A, Sorice S, Padovano A, Simmaco M, Ferracuti S, Lamis DA, Rapinesi C, Sani G, Girardi P, Kotzalidis GD, Pompili M Psychopharmacological treatment of obsessive-compulsive disorder (OCD). Curr Neuropharmacol. 2019;17(8):710–36. https://doi.org/10.2174/1570159X16666180813155017 - PMid:30101713 - PMCid:PMC7059159

Bunney W, Murphy D, Goodwin F, Borge G. The switch process from depression to mania: relationship to drugs which alter brain amines. Lancet. 1970;295(7655):1022–7. https://doi.org/10.1016/S0140-6736(70)91151-7

Amerio A, Odone A, Marchesi C, Ghaemi SN. Treatment of comorbid bipolar disorder and obsessive–compulsive disorder: a systematic review. J Affect Disord. 2014;166:258–63. https://doi.org/10.1016/j.jad.2014.05.026 - PMid:25012439

Amerio A, Maina G, Ghaemi SN. Updates in treating comorbid bipolar disorder and obsessive-compulsive disorder: a systematic review. J Affect Disord. 2019;256(June):433–40. https://doi.org/10.1016/j.jad.2019.06.015 - PMid:31234022

Goes FS, McCusker MG, Bienvenu OJ, MacKinnon DF, Mondimore FM, Schweizer B, DePaulo Jr JR, Potash JB. Co-morbid anxiety disorders in bipolar disorder and major depression: familial aggregation and clinical characteristics of co-morbid panic disorder, social phobia, specific phobia and obsessive-compulsive disorder. Psychol Med. 2012;42(7):1449–59. https://doi.org/10.1017/S0033291711002637 - PMid:22099954 PMCid:PMC3643205

Kazhungil F, Cholakottil A, Kattukulathil S, Kottelassal A, Vazhakalayil R. Clinical and familial profile of bipolar disorder with and without obsessive-compulsive disorder: an Indian study. Trends Psychiatry Psychother. 2017;39(4):270–5. https://doi.org/10.1590/2237-6089-2017-0061 - PMid:29267510

Koyuncu A, Tükel R, Özyildirim I, Meteris H, Yazici O. Impact of obsessive-compulsive disorder comorbidity on the sociodemographic and clinical features of patients with bipolar disorder. Compr Psychiatry. 2010;51(3):293–7. https://doi.org/10.1016/j.comppsych.2009.07.006 - PMid:20399339

Amerio A, Tonna M, Odone A, Stubbs B, Ghaemi SN. Course of illness in comorbid bipolar disorder and obsessive-compulsive disorder patients. Asian J Psychiatr. 2016;20(2016):12–4. https://doi.org/10.1016/j.ajp.2016.01.009 - PMid:27025465

Amerio A, Odone A, Liapis CC, Ghaemi SN. Diagnostic validity of comorbid bipolar disorder and obsessive-compulsive disorder: a systematic review. Acta Psychiatr Scand. 2014;129(5):343–58. https://doi.org/10.1111/acps.12250 - PMid:24506190

Shashidhara M, Sushma BR, Viswanath B, Math SB, Janardhan Reddy YC. Comorbid obsessive compulsive disorder in patients with bipolar-I disorder. J Affect Disord. 2015;174:367–71. https://doi.org/10.1016/j.jad.2014.12.019 - PMid:25545603

Zutshi A, Kamath P, Reddy YCJ. Bipolar and nonbipolar obsessive-compulsive disorder: a clinical exploration. Compr Psychiatry. 2007;48(3):245–51. https://doi.org/10.1016/j.comppsych.2006.12.005 - PMid:17445518

Chen YW, Dilsaver SC. Comorbidity for obsessive-compulsive disorder in bipolar and unipolar disorders. Psychiatry Res. 1995;59(1–2):57–64. https://doi.org/10.1016/0165-1781(95)02752-1

Amerio A. Suicide risk in comorbid bipolar disorder and obsessive-compulsive disorder: a systematic review. Indian J Psychol Med. 2019;41(2):133–7. https://doi.org/10.4103/IJPSYM.IJPSYM_367_18 - PMid:30983660 PMCid:PMC6436414

Dilsaver SC, Akiskal HS, Akiskal KK, Benazzi F. Dose-response relationship between number of comorbid anxiety disorders in adolescent bipolar/unipolar disorders, and psychosis, suicidality, substance abuse and familiality. J Affect Disord. 2006;96(3):249–58. https://doi.org/10.1016/j.jad.2006.07.008 - PMid:16904187

Yatham LN, Kennedy SH, Parikh S V., Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O'Donovan C, McIntosh D, Lam RW, Vazquez G, Kapczinski F, McIntyre RS, Kozicky J, Kanba S, Lafer B, Suppes T, Calabrese JR, Vieta E, Malhi G, Post RM, Berk M. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20(2):97–170. https://doi.org/10.1111/bdi.12609 PMid:29536616 - PMCid:PMC5947163

Perugi G, Cristina T, Franco F, Travierso MC, Hantouche E, Akiskal HS. Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome. J Clin Psychiatry. 2002;63(12):1129–34. https://doi.org/10.4088/JCP.v63n1207 - PMid:12523872

Amerio A, Odone A. Aripiprazole augmentation in treating comorbid bipolar disorder and obsessive-compulsive disorder. Gen Psychiatry. 2018;31(3). https://doi.org/10.1136/gpsych-2018-100007 - PMid:30582130 - PMCid:PMC6234965

Lai J, Lu Q, Zhang P, Xu T, Xu Y, Hu S. Aripiprazole augmentation in managing comorbid obsessive-compulsive disorder and bipolar disorder: a case with suicidal attempts. Neuropsychiatr Dis Treat. 2017;13:87–90. https://doi.org/10.2147/NDT.S122316 - PMid:28096676 PMCid:PMC5207469

Uguz F. Successful treatment of comorbid obsessive-compulsive disorder with aripiprazole in three patients with bipolar disorder. Gen Hosp Psychiatry. 2010;32(5):556–8. https://doi.org/10.1016/j.genhosppsych.2010.07.004 - PMid:20851277

Sahraian A, Ehsaei Z, Mowla A. Aripiprazole as an adjuvant treatment for obsessive and compulsive symptoms in manic phase of bipolar disorder: a randomized, double-blind, placebo-controlled clinical trial. Prog Neuro-Psychopharmacology Biol Psychiatry. 2018;84(March):267–71. https://doi.org/10.1016/j.pnpbp.2018.03.014 - PMid:29544694

Marazziti D, Pfanner C, Dell’Osso B, Ciapparelli A, Presta S, Corretti G, Di Nasso E, Mungai F, Dell’osso L. Augmentation strategy with olanzapine in resistant obsessive compulsive disorder: an Italian long-term open-label study. J Psychopharmacol. 2005;19(4):392–4. https://doi.org/10.1177/0269881105053299 - PMid:15982994

Petrikis P, Andreou C, Bozikas Vasilis, Karavatos A. Effective use of olanzapine for obsessive-compulsive symptoms in a patient with bipolar disorder. Can J Psychiatry. 2004;49(8):572–3. https://doi.org/10.1177/070674370404900812 - PMid:15453108

Sahraian A, Ghahremanpouri B, Mowla A. Is quetiapine effective for obsessive and compulsive symptoms in patients with bipolar disorder? A randomized, double-blind, placebo-controlled clinical trial. CNS Spectr. 2021:1-5. https://doi.org/10.1017/S1092852921000572 - PMid:34027853

Poyurovsky M, Weizman A. Quetiapine for bipolar depressive episode in obsessive-compulsive disorder patients maintained on selective serotonin reuptake inhibitor treatment. Clin Neuropharmacol. 2021;44(4):123–5. https://doi.org/10.1097/WNF.0000000000000456 - PMid:33811191

Pfanner C, Marazziti D, Dell’Osso L, Presta S, Gemignani A, Milanfranchi A, Cassano GB. Risperidone augmentation in refractory obsessive-compulsive disorder: an open-label study. Int Clin Psychopharmacol. 2000;15(5):297–301. https://doi.org/10.1097/00004850-200015050-00007 - PMid:10993132

Herstowska M, Cubała WJ. Escitalopram efficacy in obsessive-compulsive disorder comorbid with bipolar disorder. Dusunen Adam J Psychiatry Neurol Sci. 2013;26:115–116. https://doi.org/10.5350/DAJPN2013260115

Amerio A, Tonna M, Odone A, Stubbs B, Ghaemi SN. Treatment of comorbid bipolar disorder and anxiety disorders: a great challenge to modern psychiatry. Aust N Z J Psychiatry. 2015;50(7):699–700. https://doi.org/10.1177/0004867415617839 - PMid:26619897

Sahraian A, Jahromi LR, Ghanizadeh A, Mowla A. Memantine as an adjuvant treatment for obsessive compulsive symptoms in manic phase of bipolar disorder: a randomized, double-blind, placebo-controlled clinical trial. J Clin Psychopharmacol. 2017;37(2):246–9. https://doi.org/10.1097/JCP.0000000000000651 - PMid:28099183

Baer L, Minichiello WE, Jenike MA. Behavioral treatment in two cases of obsessive-complusive disorder with concomitant bipolar affective disorder. Am J Psychiatry. 1985;142(3):358–60. https://doi.org/10.1176/ajp.142.3.358 - PMid:3970279

Chang CH, Chen SY, Hsiao YL, Chen SJ, Tsai ST, Chang CH, Yu-Yin Y, Hsin-Chi T. Hypomania-like syndrome induced by deep brain stimulation of bilateral anterior limbs of the internal capsules. Prog Neuro-Psychopharmacology Biol Psychiatry. 2009;33(5):906–7. https://doi.org/10.1016/j.pnpbp.2009.04.001 - PMid:19356739

Rask O, Suneson K, Holmström E, Bäckström B, Johansson BA. Electroconvulsive therapy for manic state with mixed and psychotic features in a teenager with bipolar disorder and comorbid episodic obsessive-compulsive disorder: a case report. J Med Case Rep. 2017;11(1):1–6. https://doi.org/10.1186/s13256-017-1508-8 - PMid:29228982 - PMCid:PMC5725801

Perugi G, Akiskal HS, Pfanner C, Presta S, Gemignani A, Milanfranchi A, Lensi P, Ravagli S, Cassano G. The clinical impact of bipolar and unipolar affective comorbidity on obsessive-compulsive disorder. J Affect Disord. 1997;46(1):15–23. https://doi.org/10.1016/S0165-0327(97)00075-X

Mahasuar R, Janardhan Reddy YC, Math SB. Obsessive-compulsive disorder with and without bipolar disorder. Psychiatry Clin Neurosci. 2011;65(5):423–33. https://doi.org/10.1111/j.1440-1819.2011.02247.x - PMid:21851451

Raşit T, Serap Batmaz O, Ilker O, Banu A, Erhan E, Atiye S, Alyanak F, Atlı H. Comparison of clinical characteristics in episodic and chronic obsessive-compulsive disorder. Depress Anxiety. 2007;24(4):251–5. https://doi.org/10.1002/da.20234 - PMid:17006935

Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry. 1970;126(7):983–7. https://doi.org/10.1176/ajp.126.7.983 - PMid:5409569

Ozdemiroglu F, Sevincok L, Sen G, Mersin S, Kocabas O, Karakus K, Vahapoglu F. Comorbid obsessive-compulsive disorder with bipolar disorder: a distinct form. Psychiatry Res. 2015;230(3):800–5. https://doi.org/10.1016/j.psychres.2015.11.002 - PMid:26561371

Tükel R, Meteris H, Koyuncu A, Tecer A, Yazıcı O. The clinical impact of mood disorder comorbidity on obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci. 2006;256(4):240–5. https://doi.org/10.1007/s00406-006-0632-z - PMid:16683062

Issler CK, Amaral JAMS, Tamada RS, Schwartzmann AM, Shavitt RG, Miguel EC, Lafer B. Clinical expression of obsessive-compulsive disorder in women with bipolar disorder. Brazilian J Psychiatry. 2005;27(2):139–42. https://doi.org/10.1590/S1516-44462005000200013 - PMid:15962140

Henin A, Biederman J, Mick E, Sachs GS, Hirshfeld-Becker DR, Siegel RS, McMurrich S, Grandin L, Nierenberg AA. Psychopathology in the offspring of parents with bipolar disorder: a controlled study. Biol Psychiatry. 2005;58(7):554–61. https://doi.org/10.1016/j.biopsych.2005.06.010 - PMid:16112654

Cederlöf M, Lichtenstein P, Larsson H, Boman M, Rück C, Landén M, Mataix-Cols D. Obsessive-compulsive disorder, psychosis, and bipolarity: a longitudinal cohort and multigenerational family study. Schizophr Bull. 2015;41(5):1076–83. https://doi.org/10.1093/schbul/sbu169 - PMid:25512596 PMCid:PMC4535627

Cannon DM, Ichise M, Fromm SJ, Nugent AC, Rollis D, Gandhi SK, Klaver JM, Charney DS, Manji HK, Drevets WC. Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography. Biol Psychiatry. 2006;60(3):207–17. https://doi.org/10.1016/j.biopsych.2006.05.005 - PMid:16875929

Downloads

Publicado

2022-09-30

Como Citar

1.
Nascimento F, Olmos C, Boaventura V, Cheniaux E, Baldaçara LR, Diaz AP, Sanches M. Comorbidade entre transtorno bipolar e transtorno obsessivo-compulsivo: aspectos epidemiológicos, clínicos e terapêuticos. Debates em Psiquiatria [Internet]. 30º de setembro de 2022 [citado 7º de dezembro de 2022];12:1-27. Disponível em: https://revistardp.org.br/revista/article/view/295

Edição

Seção

Artigos de Revisão

Plaudit

Artigos mais lidos do(s) mesmo(s) autor(es)

1 2 > >>